Blockbuster Or Bust?
Of the three marijuana-based drugs that have been approved by the FDA to date, none have been big commercial successes. In contrast, this cannabinoid drug,… Read More »Blockbuster Or Bust?
Of the three marijuana-based drugs that have been approved by the FDA to date, none have been big commercial successes. In contrast, this cannabinoid drug,… Read More »Blockbuster Or Bust?
With the economy humming and airlines collecting a record amount of revenue from non-ticket fees, it should be a scorcher of a summer for U.S.… Read More »Will Airline Profits – And This ETF – Soar This Summer?
The potential for massive gains is attracting a slew of new investors to the cannabis sector. There are, however, some critical mistakes these investors will… Read More »Avoid This Marijuana Stock Mistake – And Gain An Edge Over Other Cannabis Investors
FANG stocks are not exactly cheap. But there is another group of stocks – the BANG stocks – that may be trading at a significant… Read More »Forget FANG, Buy BANG?
Despite ample evidence that women are just as good as men at managing money, the percentage of female fund managers remains stuck at less than… Read More »Which Fund Companies Are The Least Bad When It Comes To Gender Diversity?
Following the old Wall Street adage of “Sell In May & Go Away” has paid off more in some years than others. There is evidence,… Read More »“Sell In May & Go Away” – Especially This Year?
It’s the closest thing the marijuana industry has to a value stock, it just reported stellar second-quarter operating results, and it has lots for investors… Read More »A Rare Marijuana Value Stock – And Its One Big Risk
To get in this analyst’s 30-30 Club, a company has to demonstrate a 30% return on equity and a 30% earnings growth rate over several… Read More »3 Top Stock Picks From This Year’s 30-30 Club
Cape Town, South Africa is very close to ‘Day Zero’ – when its water reservoirs will be dry. And other major cities all over the… Read More »Opportunity In The Water Shortage Crisis
For the first time ever, a cannabis-based medicine has gotten a favorable recommendation from an advisory panel to the FDA. What does this major win… Read More »Big Implications From This Big Medical Cannabis Win